Guardant Health, Inc.

GH Healthcare Diagnostics & Research

Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.

Revenue
+36.1%
EPS
−25.7%
Free cash flow
+18.7%
Total debt
+34.8%

Quarter to September 2026, against a year earlier

154.16 14.42 −8.55%
Market cap
$20.6B
P/E
0.0×
Fwd P/E
−55.6×
Dividend yield
—
F-score
5/9
Altman Z
2.02
Beneish M
−2.78
Dividend safety
n/a

Guardant Health, Inc. (GH) P/B ratio

Alert me on P/B ratio

Guardant Health, Inc. has no meaningful P/B ratio: its trailing twelve-month book value is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 57.3× (January 2023) — the current reading is the lowest in ten years.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 18.7× (59.19%)
FY2022 45.8× 191.79%
FY2021 15.7× 62.34%
FY2020 9.7× 9.14%
FY2019 8.9× 274.86%
FY2018 2.4× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/B ratio Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
32 more quarters

Against its own ten years

Low 0.0× High 57.3×
Ten-year median 9.1×
Current reading's percentile 35

P/B ratio against peers

Company P/B ratio
GH Guardant Health, Inc. n/m
ICLR ICON PLC compare 1.7×
RVTY Revvity Inc. compare 2.3×
LH Labcorp Holdings Inc. compare 3.3×
DGX Quest Diagnostics Incorporated compare 3.5×
CRL Charles River Laboratories International, Inc. compare 4.6×
ILMN Illumina, Inc. compare 10.1×
MEDP Medpace Holdings, Inc. compare 30.3×
MTD Mettler-Toledo International, Inc. compare 2,631×
Diagnostics & Research industry median 3.4×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on GH